Biophage Review: Story, Cast, Rating & Final Verdict
Last updated: May 11, 2026
Movie Overview: Biophage
| Movie | Biophage |
| Release Year | 2010 |
| Director | Mark A. Rapp |
| Genre | Horror |
| Runtime | 72 minutes (1h 12m) |
| Language | EN |
Quick Verdict: Hit or Flop?
Is Biophage (2010) worth watching? According to our cinematic analysis, the film stands as a FLOP with a verified audience rating of 3.7/10. Whether you're looking for the box office collection, ending explained, or parents guide, our review covers everything you need to know about this Horror.
Cast & Character Study
The performances in Biophage are led by Aaron Jackson . The supporting cast, including Ron Marnich and John Yost , provides the necessary layers to the central narrative.
movieMx Verdict: Is it Worth Your Time?
What Works in the Movie
While Biophage does not fully realize its potential, it still contains moments that may appeal to viewers who enjoy Horror films.
- Interesting concept or premise
- Some entertaining scenes
- Supporting cast delivers occasional highlights
What Doesn't Work
Despite its strengths, Biophage has a few issues that may affect the overall viewing experience, particularly in terms of pacing and narrative consistency.
- Uneven pacing in certain parts of the film
- Some predictable plot developments
- May not appeal to audiences outside the Horror fanbase
Story & Plot Summary: Biophage
Quick Plot Summary: Released in 2010, Biophage is a Horror film directed by Mark A. Rapp, written by Steven F. Clark. The narrative crafts an atmosphere of dread and suspense, using psychological terror and visual scares. It provides a scannable look at the movie's central conflict involving Aaron Jackson as Dr. Belt.
Ending Explained: Biophage
Biophage Ending Explained: Directed by Mark A. Rapp, Biophage attempts to bring together the film’s narrative threads. The ending highlights the core horror themes developed throughout the film.
The final moments emphasize tension and lingering uncertainty, particularly in scenes involving Aaron Jackson. The interpretation of the ending may vary among viewers.
Key Elements of the Ending
- Narrative Resolution: The story resolves its primary conflict while leaving room for interpretation.
- Character Development: Character motivations become clearer by the final scenes.
- Thematic Message: The ending reinforces the horror themes introduced earlier in the film.
The final moments of Biophage reflect the creative choices of the filmmakers and align with the tone of the narrative.
Who Should Watch Biophage?
Age Advisory: Rated Not Rated.
Consider Watching If:
- You're a completist for Horror films
- You're curious despite mixed reviews
- You have low expectations and want casual entertainment
At just 72 minutes, it's a quick watch.
Biophage Parents Guide & Age Rating
2010 AdvisoryWondering about Biophage age rating or if it's safe for kids? Here is our cinematic advisory:
⏱️ Runtime & Duration
The total runtime of Biophage (2010) is 72 minutes (1h 12m). Directed by Mark A. Rapp, the film runs for 72 minutes in its complete theatrical version.
Verdict Summary
Analyzing the overall audience sentiment, verified rating of 3.7/10, and global performance metrics, Biophage is classified as a FLOP. It remains an essential part of the 2010 cinematic calendar.
Frequently Asked Questions
Is Biophage worth watching?
Biophage is definitely worth watching if you enjoy Horror movies. It has a verified rating of 3.7/10 and stands as a FLOP in our box office analysis.
Where can I find Biophage parents guide and age rating?
The official parents guide for Biophage identifies it as Not Rated. Our detailed advisory section above covers all content warnings for families.
What is the runtime of Biophage (2010)?
The runtime of Biophage (2010) is 72 minutes (approximately 1h 12m).
movieMx Verified
This review has been verified for accuracy and editorial quality by our senior cinematic analysts.
This analysis is compiled by our editorial experts using multi-source verification and audience sentiment data for maximum accuracy.
